Want to see IN:ADVENZYMES full AI Analyst Report?
Advanced Enzyme Technologies Ltd (ADVENZYMES) Financial Statements
Advanced Enzyme Technologies Ltd Financial Overview
Advanced Enzyme Technologies Ltd's market cap is currently $29.44B. The company's EPS TTM is $14.82; its P/E ratio is 17.78; and it has a dividend yield of 0.51%. Advanced Enzyme Technologies Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.46B | $ 6.37B | $ 6.23B | $ 5.41B | $ 5.29B |
| Gross Profit | $ 3.50B | $ 3.07B | $ 4.64B | $ 3.98B | $ 4.09B |
| Operating Income | $ 1.89B | $ 1.58B | $ 1.73B | $ 1.30B | $ 1.71B |
| EBITDA | $ 2.75B | $ 2.27B | $ 2.27B | $ 1.79B | $ 2.09B |
| Net Income | $ 1.69B | $ 1.31B | $ 1.33B | $ 1.06B | $ 1.20B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.00B | $ 5.88B | $ 5.48B | $ 4.86B | $ 3.74B |
| Total Assets | $ 18.39B | $ 16.21B | $ 15.35B | $ 14.22B | $ 12.68B |
| Total Debt | $ 320.09M | $ 393.50M | $ 473.08M | $ 334.99M | $ 347.30M |
| Net Debt | $ -839.22M | $ -683.35M | $ -664.43M | $ -629.21M | $ -2.33B |
| Total Liabilities | $ 1.56B | $ 1.53B | $ 1.64B | $ 1.38B | $ 1.27B |
| Stockholders' Equity | $ 16.32B | $ 14.21B | $ 13.24B | $ 12.35B | $ 10.89B |
| Cash Flow | |||||
| Free Cash Flow | $ 1.20B | $ 1.15B | $ 990.56M | $ 1.02B | $ 941.15M |
| Operating Cash Flow | $ 1.73B | $ 1.49B | $ 1.41B | $ 1.40B | $ 1.22B |
| Investing Cash Flow | $ -923.39M | $ -990.44M | $ -646.49M | $ -2.98B | $ -249.12M |
| Financing Cash Flow | $ -679.45M | $ -692.02M | $ -592.38M | $ -257.98M | $ -273.75M |
Currency in INR